Filter
1493
Filtered Results: 1493
Text search:
Ethics
in
Health
Research
Featured
Recommendations
117
New Publications
372
Language
Document type
No document type
826
Studies & Reports
322
Guidelines
172
Manuals
96
Strategic & Response Plan
29
Training Material
26
Fact sheets
15
Situation Updates
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
67
South Africa
50
Kenya
49
Global
48
Sierra Leone
45
Ethiopia
32
Nigeria
28
Malawi
28
Uganda
27
Rwanda
27
Western and Central Europe
26
Liberia
24
Zambia
23
Tanzania
21
Myanmar / Burma
21
Eastern Europe
20
Latin America and the Carribbean
18
Ghana
17
Lesotho
17
Africa
17
Syria
16
Ukraine
15
Bangladesh
13
Senegal
12
Botswana
12
Congo, Democratic Republic of
11
Brazil
11
West and Central Africa
11
Middle East and North Africa
11
Russia
11
Cambodia
10
Burkina Faso
9
Nepal
9
Indonesia
9
Mozambique
9
Benin
9
Guinea
8
East and Southern Africa
8
South–East Asia Region
8
Cameroon
7
South Sudan
7
Germany
7
Tajikistan
7
Zimbabwe
6
Philippines
6
Namibia
6
Yemen
6
Vietnam
6
Somalia
4
Ecuador
4
Eastern Europe and Central Asia
4
Southern Africa
4
Haiti
3
Pakistan
3
Thailand
3
China
3
Peru
3
Eswatini/ Swaziland
3
Colombia
3
Angola
3
Moldova
3
Kyrgyzstan
3
Kazakhstan
3
Spain
3
Mali
2
Saudi Arabia
2
Iraq
2
Afghanistan
2
Lebanon
2
Turkey
2
Sudan
2
Argentina
2
El Salvador
2
Libya
2
Guatemala
2
Madagascar
2
Paraguay
2
Asia
2
Armenia
2
Laos
2
Georgia
2
United Kingdom
2
Portugal
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Egypt
1
Chad
1
Malaysia
1
Papua New Guinea
1
North Macedonia
1
Serbia
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Palestine
1
Italy
1
Albania
1
Djibouti
1
Canada
1
Qatar
1
Iran
1
Uzbekistan
1
Australia
1
Japan
1
France
1
Authors & Publishers
Publication Years
Category
Countries
594
Clinical Guidelines
105
Women & Child Health
84
Public Health
66
Key Resources
44
Capacity Building
19
Pharmacy & Technologies
15
Annual Report MEDBOX
3
Toolboxes
HIV
127
COVID-19
124
TB
116
Mental Health
101
Caregiver
83
Ebola
46
Disability
42
Rapid Response
42
Social Ethics
42
Planetary Health
42
Global Health Education
38
NTDs
28
AMR
26
NCDs
26
Conflict
23
Pharmacy
22
Refugee
16
Health Financing Toolbox
12
Zika
11
Cholera
6
Polio
6
Natural Hazards
4
Specific Hazards
3
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
WHO Guideline on use of ferritin concentrations to assess iron status in individuals and populations
This guideline provides global, evidence-informed recommendations on the use of indicators for assessing a population’s
iron status and application of the use of ferritin concentrations for monitoring and evaluating iron interventions.
Climate change is increasing the risks of injuries, diseases, and deaths globally. However, the association between ambient temperature and renal diseases has not been fully characterized. This study aimed to quantify the risk and attributable burden for hospitalizations of renal diseases related to...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report pr...
Background
Equity and inclusion are important principles in policy development and implementation. The aim of this study is to explore the extent to which equity and inclusion were considered in th...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease ... comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive.
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability incl...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in... areas at risk, and is primarily intended for public health specialists
Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215
https://doi.org/10.1186/s12889-018-6053-xpre-
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described ... the document:
Broad spectrum Pan-African polyvalent antivenoms: products that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in pr...
